Stay updated with breaking news from Mark Levick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On August 31, 2022, Biocon Biologics released a statement regarding three recent on-site FDA inspections of seven manufacturing facilities spanning two sites in Bengaluru, India...
Alvotech (NASDAQ:NASDAQ:ALVO) Q2 2022 Earnings Conference Call September 1, 2022 08:00 ET Company Participants Benedict Stephan - Investor Relations Robert Wessman - Executive Chairman...
Alvotech releases ESG indicators covering both 2020 and 2021 Carbon neutrality for scope 1 and 2 emissions achieved in 2020 and 2021ESG portal is now...
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
The confirmatory clinical, safety and efficacy study for AVT04, biosimilar candidate to Stelara (ustekinumab) met its primary endpoint AVT04 (ustekinumab) is part of a broader pipeline of